e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem
A. Sadigov, J. Mammadov, G. Alieva (Baku, Azerbaijan)
Source:
Annual Congress 2011 - COPD management
Session:
COPD management
Session type:
Thematic Poster Session
Number:
543
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sadigov, J. Mammadov, G. Alieva (Baku, Azerbaijan). How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem. Eur Respir J 2011; 38: Suppl. 55, 543
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019
Year: 2019
Emerging anti-inflammatory strategies for COPD},
Source: Eur Respir J 2012; 40: 724-741
Year: 2012
Combination therapy for chronic obstructive pulmonary disease: one size fits all?
Source: Eur Respir J 2003 Dec 01;22(6):874-875
Year: 2003
Searching for chronic obstructive pulmonary disease in the over 65 people: suggestions for a cost-effective approach
Source: Eur Respir J 2004; 24: Suppl. 48, 360s
Year: 2004
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Does the application of an algorithm for non-invasive ventilation in chronic obstructive pulmonary disease improve the initiation process, and patient outcomes?
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009
The peculiarities of current chronic obstructive pulmonary disease among women of Taymir
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Does self-management ability improve after pulmonary rehabilitation for chronic obstructive pulmonary disease?
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019
Patients and families realizing their future with chronic obstructive pulmonary disease - a qualitative study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017
Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation?
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007
Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003
Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept